Hyperhidrosis diagnosis, management consensus statement published Guideline 30 January 2013 Pages: 2 - 2
Guideline for managing paediatric otitis media with effusion released Guideline 30 January 2013 Pages: 4 - 4
New global malaria initiative supports artemisinin-based therapy Comment 30 January 2013 Pages: 4 - 4
High-dose chronic use of rofecoxib among elderly a concern Clinical study 30 January 2013 Pages: 5 - 5
Antibacterials overused for acute bronchitis among elderly Clinical study 30 January 2013 Pages: 6 - 6
Basiliximab good value for money in renal transplantation Clinical study 30 January 2013 Pages: 6 - 6
Reduced hospitalisation contributes to diabetes DM cost savings Clinical study 30 January 2013 Pages: 6 - 6
Ciclosporin monitoring: 2-hour post-dose strategy cost saving Clinical study 30 January 2013 Pages: 7 - 7
Discrepancy between hypertension guidelines and clinical practice Clinical study 30 January 2013 Pages: 7 - 7
Costs similar for methotrexate, ciclosporin in plaque psoriasis Clinical study 30 January 2013 Pages: 8 - 8
Bicalutamide as adjuvant therapy warranted in early prostate cancer Clinical study 30 January 2013 Pages: 9 - 9
Clopidogrel cost effective for prevention of vascular events? Clinical study 30 January 2013 Pages: 9 - 9
IV PPIs best strategy following endoscopy for bleeding ulcer Clinical study 30 January 2013 Pages: 9 - 9
Hyperhidrosis prevalence has economic implications in the US Clinical study 30 January 2013 Pages: 10 - 10
Value of nevirapine for preventing MTCT of HIV infections in Africa Clinical study 30 January 2013 Pages: 11 - 11
Dipyridamole plus aspirin cost effective in stroke prevention Clinical study 30 January 2013 Pages: 12 - 12
Escitalopram cost effective vs citalopram for depression in Austria Clinical study 30 January 2013 Pages: 12 - 12
Antipsychotic-induced metabolic disturbances reduce QOL Clinical study 30 January 2013 Pages: 13 - 13
Radiolabelled octreotate particularly useful in patients with regression Clinical study 30 January 2013 Pages: 13 - 13
Epoetin alfa plus lenograstim costly, no QOL benefit in anaemia Clinical study 30 January 2013 Pages: 14 - 14
WHO's development of new growth standards receives cash boost Media release 30 January 2013 Pages: 15 - 15